Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma.
Coni S, Mancuso AB, Di Magno L, Sdruscia G, Manni S, Serrao SM, Rotili D, Spiombi E, Bufalieri F, Petroni M, Kusio-Kobialka M, De Smaele E, Ferretti E, Capalbo C, Mai A, Niewiadomski P, Screpanti I, Di Marcotullio L, Canettieri G.
Coni S, et al. Among authors: kusio kobialka m.
Sci Rep. 2017 Mar 9;7:44079. doi: 10.1038/srep44079.
Sci Rep. 2017.
PMID: 28276480
Free PMC article.